About Doseworth

Nearly every price advertised in GLP-1 telehealth is a number you will not pay for long. It is a first-month rate, or the monthly equivalent of a twelve-month prepay, or a figure that assumes a starting dose you will move off within weeks. The advertised price is engineered for the comparison you make before you buy. The price that matters is the one you are still paying in month seven.

Doseworth exists to close that gap. We read what providers charge on their own pages, write down what one cycle costs if you simply stop after it, multiply by the number of times they will actually bill you in a year, and publish the result next to the date we read it. It is not sophisticated work. It is arithmetic nobody in this market has any commercial reason to do on your behalf.

• Price boards — every provider we have priced for a given compound, sorted by what a year actually costs, cheapest first, with the capture date and the source page on every row.
• Provider reviews — what one company charges per compound, what its billing structure does to the annual total, and the terms that catch people out. No score out of ten: a score is a marketing device on a site whose subject is honest pricing.
• FDA warning-letter records — a factual account of letters issued to companies in this market, quoting FDA's own language and linking to fda.gov. We disclose letters; we do not treat one as disqualifying.
• Research — background on how these drugs, doses and coverage rules work, cited to primary sources.

Doseworth is edited by Marla Whitfield, Pricing Editor. Marla tracks what GLP-1 and peptide treatment actually costs — cash, insured, and compounded — and checks every published price against the provider's own checkout before it runs on Doseworth.

That byline claims competence in pricing and billing structures and no medical credential, which is the accurate description of what happens here. There is no medical review board behind this site and no clinician reviews these pages on our behalf — if that ever changes, the reviewer will be named on the pages they actually reviewed. The full inventory of what we do and do not have is in the editorial policy.

Affiliate commission. If you follow one of our links to a provider and become a customer, that provider may pay us a share of its own margin. You pay the same price you would have paid arriving any other way.

What that money does not do is change a price. On the /best boards, companies that pay us are listed in a first group and everyone else follows, and each board says so at the top; within each group the order is computed from the price rows. The /cheapest boards have no partner group and sort on price alone. Every figure is read from the company's own page and is the same either way. The full account is on the disclosure page.

Not a pharmacy, not a telehealth provider, not a medical practice, not an insurer, not a laboratory. We do not test, prescribe, dispense, compound or sell anything, and nothing on this site is medical advice or creates any clinical relationship with you — see the medical disclaimer, which is specific about compounded drugs in particular.

editor@doseworth.com. A wrong price is the most useful thing you can send us, and the corrections page sets out what to include and what we do with it. Also here: terms of use · privacy policy · editorial policy.